(S)-5-(Allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid

Catalog No. :
ACLVQJ091
CAS No. :
132286-79-4
Molecular Formula :
C13H21NO6
Molecular Weight :
287.31

IUPAC Name:(S)-5-(allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid

(S)-5-(Allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$136.00Login to see priceInquiryInquiry
10g95%$233.00Login to see priceInquiryInquiry
25g95%$466.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-5-(Allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid
IUPAC Name(S)-5-(allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid
MDL No.MFCD00273402
Molecular FormulaC13H21NO6
Molecular Weight287.31
SMILESO=C(O)[C@@H](NC(OC(C)(C)C)=O)CCC(OCC=C)=O
InChI KeyVNZYUMCXQWYCAW-VIFPVBQESA-N
SynonymC13H21NO6 | MFCD00273402 | (S)-5-(Allyloxy)-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid | N-alpha-t-Butyloxycarbonyl-L-glutamic acid beta-allyl ester (Boc-L-Glu(OAll)-OH) | 5-(2-Propen-1-yl) hydrogen N-[(1,1-dimethylethoxy)carbonyl]-L-glutamate | F
CAS No.132286-79-4
PubChem CID14779838

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLVQJ091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVQJ091 route product structure diagram
    ACLVQJ091132286-79-4
Inquiry

2. ACLVQJ091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLVQJ091 route product structure diagram
    ACLVQJ091132286-79-4
Inquiry

Comments (0)